Individualized Care in COPD: Updated Guidelines from Revised GOLD 2017 Report
Journal Title: Chronic Obstructive Pulmonary Disease: Open Access - Year 2017, Vol 2, Issue 2
Abstract
Chronic obstructive lung disease (COPD) is a major cause of morbidity and mortality around the world. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) program provides evidence based guidelines to optimize management of patients with COPD. The Global Strategy for Diagnosis, Management and Prevention of COPD 2017 report incorporates many changes based on updated research published through 2016. It includes new strategies to promote individualized care with the goal of improving patient-centered outcomes. The new definition, revised combined assessment tool and the new approaches to management of COPD are highlighted in our review.
Authors and Affiliations
Jatan Shah, Nevin Uysal-Biggs, Kavita Ratarasarn
COPD Treatment in Real Life and Randomized Controlled Trials: Is There Any Difference between Both Settings?
In the last decade, for treatment of patients with chronic obstructive pulmonary disease (COPD) a myriad of new medications, mostly administered in new inhalation devices were introduced on the market. In addition, All,...
Incentive for the Research that Highlights the Relationship between Smoking and the Development of Chronic Obstructive Pulmonary Disease (COPD)
Smoking, one of the most important public health problems, is responsible for a large number of preventive deaths in the world. It is also the main risk factor for the development of numerous diseases. For the last few d...
Characterization of Smoking Habits Patterns in Medical Doctors of a Central Hospital in PortugalâÂÂWhat has Changed after 15 Years? A Comparative CrossSectional Study
Introduction: Tobacco dependence remains one of the primary health care concerns worldwide. Attitude of healthcare professionals towards smoking is crucial for any long-term prevention and smoking cessation program. Obj...
Validation of the COPD Assessment Test in Patients with COPD in Iran
Background: Chronic obstructive pulmonary diseases (COPD) is among the most important causes of chronic disease in adulthood. COPD assessment test (CAT) and Saint George Respiratory Questionnaire (SGRQ) are two health re...
Thrombomodulin for Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Background: Acute exacerbation (AE) is known as a leading cause of morbidity and mortality in chronic fibrosing group includes idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP). There is n...